Fintel on MSN9h
HC Wainwright & Co. Initiates Coverage of ImmunityBio (IBRX) with Buy Recommendation
Fintel reports that on March 6, 2025, HC Wainwright & Co. initiated coverage of ImmunityBio (NasdaqGS:IBRX) with a Buy ...
Kalkine Media4h
How ImmunityBio, Inc. (NASDAQ:IBRX) Is Navigating Market Trends and Institutional Shifts
Highlights,The New York State Common Retirement Fund raised its stake in ImmunityBio by 62.8% in the fourth quarter.,Several ...
ImmunityBio initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Andres Maldonado initiated coverage of ImmunityBio (IBRX) with a Buy rating and $8 price target ImmunityBio is a ...
Soft Tissue Sarcoma Market on Track for Major Expansion by 2032, According to DelveInsight | Moleculin Biotech
The Soft Tissue Sarcoma market is expected to surge due to the disease's increasing prevalence and awareness during the ...
This Tourmaline Bio Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, ...
Merkel Cell Carcinoma Market is Expected to Advance at a CAGR of 8.7% During the Study Period (2020-2034) | DelveInsight
The Merkel Cell Carcinoma Market is expected to grow significantly in the 7MM, driven by the rising awareness among ...